HealthCor Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

HealthCor Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-229,530	Closed	-$14.2M	–	65
2022 Q3	$14.2M	Sell	229,530 -674,320	-75%	-$47.1M	1.78%	24
2022 Q2	$72.1M	Buy	903,850 +193,740	+27%	+$18.3M	7.24%	2
2022 Q1	$74.7M	Sell	710,110 -122,160	-15%	-$11.9M	4.98%	3
2021 Q4	$89.7M	Sell	832,270 -445,958	-35%	-$48.6M	4.88%	4
2021 Q3	$140M	Buy	1,278,228 +43,180	+3%	+$4.48M	6.04%	2
2021 Q2	$116M	Sell	1,235,048 -490,602	-28%	-$45.1M	4.62%	3
2021 Q1	$159M	Sell	1,725,650 -392,440	-19%	-$33.1M	5.62%	1
2020 Q4	$155M	Buy	2,118,090 +327,780	+18%	+$24.4M	5.98%	1
2020 Q3	$139M	Buy	1,790,310 +1,389,270	+346%	+$95.6M	5.57%	4
2020 Q2	$22.3M	Sell	401,040 -393,440	-50%	-$16.8M	0.93%	32
2020 Q1	$23.5M	Buy	+794,480	New	+$26.9M	1.01%	28
2019 Q4	–	Sell	-2,628,840	Closed	-$71.6M	–	75
2019 Q3	$71.6M	Sell	2,628,840 -164,830	-6%	-$4.26M	2.71%	16
2019 Q2	$67.2M	Buy	2,793,670 +802,341	+40%	+$20.4M	2.61%	13
2019 Q1	$52.6M	Buy	+1,991,329	New	+$47.2M	2.13%	19
2016 Q4	–	Sell	-4,250,000	Closed	-$77.1M	–	52
2016 Q3	$77.1M	Buy	+4,250,000	New	+$83M	4.7%	7
2015 Q3	–	Sell	-3,200,000	Closed	-$111M	–	65
2015 Q2	$111M	Sell	3,200,000 -800,000	-20%	-$24.4M	5.6%	5
2015 Q1	$104M	Sell	4,000,000 -1,600,000	-29%	-$29.3M	4.96%	1
2014 Q4	$72.2M	Buy	5,600,000 +2,025,000	+57%	+$25.3M	4.02%	6
2014 Q3	$43.9M	Buy	3,575,000 +875,000	+32%	+$10.2M	2.25%	21
2014 Q2	$42.7M	Buy	+2,700,000	New	+$38.5M	2.14%	22

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HealthCor Management's HZNP Position: Q4 2022 in Review

HealthCor Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 229,530 shares — an estimated $14.2M sold.

HealthCor Management first reported a position in HZNP in Q2 2014 and held it in 20 quarters. The position peaked at $159M in Q1 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

HealthCor Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
HealthCor Management sold 229,530 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $14.2M.
HealthCor Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2014 and held it in 20 quarters.
HealthCor Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $159M in Q1 2021.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.